Effepharm Started New Clinical Trials on Uthever™

NEW YORK--()--Effepharm Ltd declared new clinical trials on UtheverTM - its branded NMN(Nicotinamide Mononucleotide) ingredient recently. The clinical trial on UtheverTM is the largest scale trial on NMN in the world according to ICTRP(WHO’s International Clinical Trials Registry Platform). “Effepharm is the first and the only NMN ingredient manufacturer until now to conduct clinical trials in the world. We believe UtheverTM will stand the test of time and become the golden standard of NMN,” said Dr. Yu, R&D director at Effepharm. “It’s our duty to assure the quality of UtheverTM and protect people from inferior NMN raw material, which will lead to poor quality final products.”

We have conducted lots of animal studies on UtheverTM previously and some projects are still ongoing. Why are we conducting human studies as a raw material manufacturer? We know the link between animal and human study, we also know the difference between them. We’ll never put our customers at risk,” Dr. Yu added.

A multicenter, randomized, double-blind, parallel design, placebo-controlled study was the most objective method to evaluate the efficacy and safety of UtheverTM. It is widely used and accepted by pharmaceutical R&D. Effepharm is trying to let the public know what they do, how they do and why they do.

Transparency and science are the bridge to trust. Effepharm is not only a professional NMN R&D center but also an information center where the public can get scientific knowledge about NMN and other dietary ingredients. “By our endeavors, more and more people will know UtheverTM and benefit from UtheverTM, ” said Dr.Yu.

IDS(Ingredient Delivery System) is Effepharm’s unique application platform to solve problems like dissolution, stability, taste, bioavailability, etc. Qinyuan Xu, Production Director of Effepharm, said “We can now customize the density of UtheverTM NMN bulk materials to avoid cross-contamination and decrease the loss during formulation with the help of IDS. For example, high-density UtheverTM is more appropriate to be used to produce tablets and capsules to minimize their sizes.” By applying innovative techniques, IDS is a very powerful tool. UtheverTM is more stable at room temperature which is critical for easy storage and shipment and can significantly prolong the shelf life.

The attraction of NMN is continuously growing. In a sea of fake materials, UtheverTM never compromises on quality.

Contacts

Effepharm
Amy Sheng
amy.sheng@effepharm.com

Contacts

Effepharm
Amy Sheng
amy.sheng@effepharm.com